Welcome
The Tanz Centre for Research in Neurodegenerative Diseases at the University of Toronto is a world leader in scientific research on Alzheimer’s and other dementias, ALS, and Parkinson’s.
Our highly productive researchers and trainees are advancing knowledge of these debilitating brain disorders, from genetics and molecular mechanisms of disease through to translational research driving for better treatments and strategies for prevention.
Sep 30, 2024
Naomi Visanji met Jonathan Rezek in 2015. Rezek, an IBM executive who had Parkinson’s disease, was a patient in the movement disorders clinic at Krembil Brain Institute, University Health Network. He had the idea that Visanji work with her colleagues and IBM’s Watson artificial intelligence to look for new treatments for Parkinson’s disease.
Aug 8, 2024
Professor Anthony Lang and an international research group proposed a new biological classification system for Parkinson’s disease, which will help focus research and may influence future patient care.
May 2, 2024
Rare genetic mutations that cause early-onset Alzheimer’s disease are helping scientists at the University of Toronto uncover mechanisms involved in the disease, which may lead to new diagnostic tools and therapies.
With Your Support
With our new leadership and your investment, we will stimulate new research pathways towards understanding neurodegenerative diseases.
